Jg. Fodor, COMPARATIVE EFFICACY AND TOLERABILITY OF NISOLDIPINE COAT CORE AND HYDROCHLOROTHIAZIDE IN MILD-TO-MODERATE HYPERTENSION, International journal of clinical practice, 51(5), 1997, pp. 271-275
This study compared the efficacy and tolerability of nisoldipine coat
core (CC) 10-40 mg o.d. and hydrochlorothiazide (HCTZ) 25-50 mg o.d. P
atients with mild-to-moderate essential hypertension received either n
isoldipine CC 10 mg o.d. or HCTZ 25 mg o.d. Treatment was titrated at
two-weekly intervals as necessary. The primary efficacy endpoint was a
defined reduction in diastolic blood pressure (DBP). Response rates w
ere similar for both the nisoldipine CC-and HCTZ-treated groups (74% a
nd 70%, respectively). Secondary efficacy endpoints were reductions in
both diastolic and systolic blood pressures (SEP). At treatment endpo
int, the change from baseline in SEP was 16.2 mmHg for the nisoldipine
CC group and 14.9 mmHg for the HCTZ group. Both drugs were weil toler
ated, and adverse events were generally minor and typical of these ant
ihypertensive agents. Drug-related adverse events were greater in the
nisoldipine CC-than the HCTZ-treated patients (50% and 37%, respective
ly). Nisoldipine CC was shown to demonstrate antihypertensive efficacy
similar to HCTZ in the treatment of mild-to-moderate hypertension.